日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MiR-181a-5p/CDK6 axis attenuates cell proliferation, migration and glycolytic reprogramming in oral squamous cell carcinoma.

miR-181a-5p/CDK6 轴减弱口腔鳞状细胞癌的细胞增殖、迁移和糖酵解重编程。

Gao Jiping, Yang Yiyan, Chang Xiaoqi, Wang Xiaotang, Zhang Zhaorui, Shi Shuxuan, Liu Yaqi, Su Jinjin, Chen Zhaoyang, Sun Rui, Song Guohua

Targeting cell cycle and apoptotic pathways with newly synthesized diselenide-linked imidazolone analogues with strong CDK6-targeting potential

利用新合成的具有强 CDK6 靶向潜力的二硒化物连接的咪唑酮类似物靶向细胞周期和凋亡通路

Abdel-Motaal, Marwa; Shaaban, Saad; Hawas, Samia S; Elsharif, Asma M; Sharaky, Marwa; Alatawi, Fatema S; Eissa, Mohamed E; Al Khatib, Arwa Omar; Abd El-Lateef, Hany M; Asem, Medhat; Al-Karmalawy, Ahmed A

Molecular docking and dynamics reveal novel CDK6 inhibitors for targeted glioblastoma therapy

分子对接和动力学研究揭示了用于靶向胶质母细胞瘤治疗的新型 CDK6 抑制剂

Khan, Muhammad Umer; Munir, Maha; Manzoor, Hina; Hamad, Ismail; Chohan, Tahir Ali; Alotaibi, Badriyah S

Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer

癌症中 CDK4 和 CDK6 激酶靶向治疗的耐药机制和治疗策略

Asciolla, James J; Wu, Xuewei; Adamopoulos, Christos; Gavathiotis, Evripidis; Poulikakos, Poulikos I

Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis

组蛋白去乙酰化酶通过 CDK6/ID2 轴促进 Th17 细胞分化和自身免疫性葡萄膜炎的致病性。

Chun Zhang ,Xiuxing Liu ,Chenyang Gu ,Yuhan Su ,Jianjie Lv ,Yidan Liu ,Yuehan Gao ,Hui Chen ,Nanwei Xu ,Jing Xiao ,Zhuping Xu ,Wenru Su

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

帕博西尼治疗 CDK4 或 CDK6 扩增肿瘤患者的 II 期研究:NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案 Z1C 的结果

O'Hara, Mark H; Jegede, Opeyemi; Dickson, Mark A; DeMichele, Angela M; Piekarz, Richard; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Lawrence V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Onitilo, Adedayo; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Comment on "IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m(6)A dependent manner"

评论“IGF2BP3通过m(6)A依赖的方式增强CDK6 mRNA的稳定性,从而促进膀胱癌细胞的增殖和顺铂耐药性”

Han, Yongzheng; Li, Chengming; Wu, Guangzhen

IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner

IGF2BP3通过m6A依赖的方式增强CDK6 mRNA的稳定性,从而促进膀胱癌细胞的增殖和顺铂耐药性。

Song, Qiang; Wang, Wei; Yu, Hao; Zhou, Zijian; Zhuang, Juntao; Lv, Jiancheng; Jiang, Linjing; Yang, Xiao; Lu, Qiang; Yang, Haiwei

Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML

双重靶向 CDK6 和 LSD1 具有协同作用,可克服急性髓系白血病 (AML) 中的分化阻滞。

Lise Brault ,Edwige Voisset ,Mathieu Desaunay ,Antonia Boudet ,Paraskevi Kousteridou ,Sébastien Letard ,Nadine Carbuccia ,Armelle Goubard ,Rémy Castellano ,Yves Collette ,Julien Vernerey ,Isabelle Vigon ,Jean-Max Pasquet ,Patrice Dubreuil ,Sophie Lopez ,Paulo De Sepulveda

Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma.

黑色素瘤中干细胞标志物 CBX3 诱导 p21/CDK6 通路并改变免疫微环境

Chen Wanxian, Zhou Linsa, Jiang Jingjing, Chen Jiasheng, Geng Deyi, Chen Yaokun, Han Xiaosha, Xie Qihu, Guo Genghong, Chen Xuefen, Tang Shijie, Zhong Xiaoping